FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

Citius Oncology, Inc.: cost_of_revenue

One fact, its scope and the complete path back to the official record.

Period: 2025-10-01 – 2026-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/fe88f63e-ca9f-46b8-bff2-95a3d89e3f12

Reported value

$1.118M{"amount": 1118086, "concept": "us-gaap:CostOfRevenue", "currency": "USD"}
Entity
Citius Oncology, Inc.
Metric
cost_of_revenue
Period
2025-10-01 – 2026-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001213900-26-057841 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T18:38:39.302495+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001851484/cost-of-revenue/2026-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.